Author:
Levine Michael,Culbreth Rachel,Amaducci Alexandra,Calello Diane P.,Shulman Joshua,Judge Bryan,Love Jennifer,Hughes Adrienne,Schwarz Evan S.,Carpenter Joseph,Wax Paul,Aldy Kim,Krotulski Alex J.,Logan Barry K.,Buchanan Jennie,Brent Jeffrey,Meaden Christopher W.,Hendrickson Robert G.,Abston Stephanie,Li Shao,Campleman Sharan,Manini Alex F.
Funder
National Institute on Drug Abuse
National Institutes of Health
Reference26 articles.
1. Agency for Healthcare Research and Quality, 2023. Potentially Avoidable Hospitalizations. Emergency Visits for Opioid Use Rose While Treatment for Illicit Drug Use Remained Unchanged. 〈https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/qdr-data-spotlight-opioids-edvisits-tx.pdf〉 (Accessed August 10, 2023).
2. Naloxone use in novel potent opioid and fentanyl overdoses in emergency department patients;Amaducci;JAMA Netw. Open,2023
3. Defining and improving data quality in medical registries: a literature review, case study, and generic framework;Arts;J. Am. Med. Inf. Assoc.,2002
4. Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV;Campbell;Am. J. Prev. Med.,2013
5. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis;Ciccarone;Curr. Opin. Psychiatry,2021